» Articles » PMID: 24351650

The Glycolytic Enzyme PFKFB3/phosphofructokinase Regulates Autophagy

Overview
Journal Autophagy
Specialty Cell Biology
Date 2013 Dec 20
PMID 24351650
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

T lymphocytes, the master regulators of immunity, have an unusual lifestyle. Equipped with a clonally distributed receptor they remain resting for long periods of time but go into overdrive when encountering antigen. Antigen recognition triggers an activation program that results in massive proliferation, differentiation into effector/memory cells, egress from lymphoid storage sites, and production of an array of cytokines. To adapt to the sudden demand for energy and biosynthetic macromolecules, T cells resort to aerobic glycolysis, relying on the Warburg effect to provide sufficient ATP and precursor molecules. Metabolic adaptation to the biosynthetic needs includes upregulation of autophagy, a catabolic process resulting in the degradation of cytoplasmic contents. The close connection between a metabolic switch, proliferative expansion, and functional differentiation connects the metabolic conditions in the cell to normal and pathogenic immunity.

Citing Articles

Multilevel plasticity and altered glycosylation drive aggressiveness in hypoxic and glucose-deprived bladder cancer cells.

Peixoto A, Ferreira D, Miranda A, Relvas-Santos M, Freitas R, Veth T iScience. 2025; 28(2):111758.

PMID: 39906564 PMC: 11791300. DOI: 10.1016/j.isci.2025.111758.


Inhibition of sympathetic tone via hypothalamic descending pathway propagates glucocorticoid-induced endothelial impairment and osteonecrosis of the femoral head.

Shao W, Wang B, Wang P, Zhang S, Gong S, Guo X Bone Res. 2024; 12(1):64.

PMID: 39516484 PMC: 11549335. DOI: 10.1038/s41413-024-00371-3.


Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications.

Panahi Meymandi A, Akbari B, Soltantoyeh T, Hadjati J, Klionsky D, Badie B Front Immunol. 2023; 14:1212695.

PMID: 37675121 PMC: 10477670. DOI: 10.3389/fimmu.2023.1212695.


PFKFB3 Inhibitor 3PO Reduces Cardiac Remodeling after Myocardial Infarction by Regulating the TGF-β1/SMAD2/3 Pathway.

Yang Q, Zong X, Zhuang L, Pan R, Tudi X, Fan Q Biomolecules. 2023; 13(7).

PMID: 37509108 PMC: 10377206. DOI: 10.3390/biom13071072.


Role of PFKFB3-driven glycolysis in sepsis.

Xiao M, Liu D, Xu Y, Mao W, Li W Ann Med. 2023; 55(1):1278-1289.

PMID: 37199341 PMC: 10198010. DOI: 10.1080/07853890.2023.2191217.